The Business of Autism: Private Equity, Medicaid & the Cost of Care Jeff ByersandDaniel R. Arnold August 28, 2026

https://www.healthaffairs.org/do/10.1377/hp20260827.806800/full/?utm_campaign=podcast&utm_medium=email&_hsenc=p2ANqtz--l0lIBA0eiUdE-xwVIOYDLBNrJMXItdpXQviZtcXCLpiJKpQLdEe_8u98OSlaFfbSGWmVNIePlFVWSSZy1of87j7O4oA&_hsmi=435825747&utm_content=hatw&utm_source=hasu Dan Arnold discusses the growth of Medicaid-funded autism treatment, the influence of private equity, and the challenge of managing costs while preserving access to care.